Shannon M. Hansen - 17 Nov 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Signature
/s/ Shannon M. Hansen
Issuer symbol
TNDM
Transactions as of
17 Nov 2025
Net transactions value
-$7,962
Form type
4
Filing time
19 Nov 2025, 16:06:23 UTC
Previous filing
19 Aug 2025
Next filing
19 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hansen Shannon Marie EVP & Chief Legal Officer 12400 HIGH BLUFF DRIVE, SAN DIEGO /s/ Shannon M. Hansen 19 Nov 2025 0001908267

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Award $12,472 +800 +4.3% $15.59 19,509 17 Nov 2025 Direct F1
transaction TNDM Common Stock Options Exercise $0 +530 +2.7% $0.000000 20,039 17 Nov 2025 Direct
transaction TNDM Common Stock Tax liability $3,536 -190 -0.95% $18.61 19,849 17 Nov 2025 Direct F2
transaction TNDM Common Stock Options Exercise $0 +1,437 +7.2% $0.000000 21,286 17 Nov 2025 Direct
transaction TNDM Common Stock Tax liability $9,584 -515 -2.4% $18.61 20,771 17 Nov 2025 Direct F2
transaction TNDM Common Stock Options Exercise $0 +1,096 +5.3% $0.000000 21,867 17 Nov 2025 Direct
transaction TNDM Common Stock Tax liability $7,314 -393 -1.8% $18.61 21,474 17 Nov 2025 Direct F2
holding TNDM Common Stock 1,935 17 Nov 2025 Shannon M. Hansen Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -530 -50% $0.000000 531 17 Nov 2025 Common Stock 530 Direct F4, F5, F6
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,437 -33% $0.000000 2,874 17 Nov 2025 Common Stock 1,437 Direct F7, F8, F9
transaction TNDM Restricted Stock Unit Options Exercise $0 -1,096 -14% $0.000000 6,581 17 Nov 2025 Common Stock 1,096 Direct F8, F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2025, through November 17, 2025. This transaction is also exempt under Rule 16b-3(c).
F2 Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F3 The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee.
F4 Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F5 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F6 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F7 Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F8 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F9 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F10 Awarded on May 23, 2024 pursuant to the 2023 Plan.
F11 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.